News

Emerging Capex Cycle Set to Propel SMID Stocks for Growth

Emerging Capex Cycle Set to Propel SMID Stocks for Growth

Emerging Capex Cycle Poised to Boost SMID Stocks

Analysts at Bank of America are predicting a major capital expenditure (capex) cycle is on the way, which is especially favorable for small- and mid-cap (SMID) stocks alongside various other sectors.

Key Drivers of the Capex Cycle

This revitalized capex cycle is driven by several factors, including reshoring efforts, urgent infrastructure requirements in the U.S., and escalating global geopolitical tensions. These elements are contributing to an uptick in spending related to manufacturing, infrastructure, and technology, as outlined by Bank of America.

Impact of Reshoring Trends

Reshoring, which has gained traction in recent years, has accelerated due to challenges from the pandemic and geopolitical tensions in different parts of the world. Bank of America highlights that companies are increasingly focused on protecting their intellectual property and reducing vulnerabilities in their supply chains. This urgency has resulted in a significant increase in manufacturing investments within the United States.

Manufacturing Investments and Infrastructure Challenges

The bank reports a remarkable uptick in manufacturing spending, marking the largest rise in over ten years, driven by a focus on AI advancements. Furthermore, the U.S. is grappling with an aging infrastructure crisis. Years of underinvestment have left many non-residential assets and structures in critical condition; some are the oldest they've been in seventy years. Currently, the American Society of Civil Engineers has assigned a C- grade to U.S. infrastructure, signaling an urgent need for upgrades.

Adding to this, the rising number of miles driven since 2010 highlights the growing necessity to improve and innovate roads, bridges, and utilities across the country.

Evolving Financial Landscape and Investment Shifts

As real interest rates rise, the financial landscape is changing noticeably. Long-term growth projects that once thrived in a zero-interest environment now face increased pressure to deliver higher returns. Bank of America notes that this shift has led to a significant influx of private equity investments into physical infrastructure, with funding for these projects outpacing technology investments by a factor of six.

SMID Caps Stand to Gain from the Growth

In light of these trends, small- and mid-cap stocks are well-positioned to benefit, as their sales growth becomes increasingly aligned with this surge in capex, particularly in areas related to “picks and shovels.” Sectors like utilities, industrials, and real estate are especially primed to take advantage of these opportunities.

Frequently Asked Questions

What is driving the current capex cycle?

The current capex cycle is primarily driven by reshoring initiatives, infrastructure demands, and geopolitical tensions, which together lead to increased spending across various sectors.

How does reshoring affect manufacturing investments?

Reshoring positively influences manufacturing investments, as companies aim to mitigate supply chain risks and safeguard intellectual property, resulting in increased domestic investments.

What is the state of U.S. infrastructure?

The state of U.S. infrastructure is notably poor, receiving a C- grade from the American Society of Civil Engineers, highlighting the urgent need for modernization and repairs.

How have interest rates impacted investment trends?

With rising real interest rates, investment trends are shifting toward projects that promise higher returns. This shift is leading to a noticeable increase in private equity directed toward physical infrastructure.

Why are SMID caps expected to benefit from these trends?

SMID caps are expected to benefit as their sales growth closely aligns with rising capital expenditures, particularly in the utilities, industrials, and real estate sectors.

About The Author

About Investors Hangout

Investors Hangout is a leading online stock forum for financial discussion and learning, offering a wide range of free tools and resources. It draws in traders of all levels, who exchange market knowledge, investigate trading tactics, and keep an eye on industry developments in real time. Featuring financial articles, stock message boards, quotes, charts, company profiles, and live news updates. Through cooperative learning and a wealth of informational resources, it helps users from novices creating their first portfolios to experts honing their techniques. Join Investors Hangout today: https://investorshangout.com/

The content of this article is based on factual, publicly available information and does not represent legal, financial, or investment advice. Investors Hangout does not offer financial advice, and the author is not a licensed financial advisor. Consult a qualified advisor before making any financial or investment decisions based on this article. This article should not be considered advice to purchase, sell, or hold any securities or other investments. If any of the material provided here is inaccurate, please contact us for corrections.

Top 10 Most Recent News Articles

Decoding Insurance Choices: Tulsa Drivers' Dilemma

Updated Category News Views 8

Insurance Jargon: Navigating the Tulsa Terrain Insurance. If you’ve ever tried to wrap your head around this beast, you know it’s not the friendliest thing on the block. For the folks in Tulsa, Oklahoma, understanding the difference between full coverage and liability insurance isn’t just an idle exercise—it's critical. There's more at stake than just a piece of...

Continue Reading
BIOCORNEUM Adds Mineral SPF 30 to Scar Gel Lineup

Updated Category News Views 3

Scar Care Just Got an Upgrade with Mineral SPF 30 BIOCORNEUM's kicking it up a notch by introducing Mineral SPF 30 to their repertoire, a move that pivots their scar management tech firmly into the sun protection arena. If you've been around the block with skincare, you know scars need special treatment—and it ain't just about slapping on any old cream. With the...

Continue Reading
GABA Therapeutics' 2026 Annual Meeting Notice Rundown

Updated Category News Views 3

The paperwork is in, folks, and it's time for GABA Therapeutics to gather its clan of stockholders come September 10, 2026. Located in that corporate mecca, a.k.a. Newport Beach, California, motives are plain—vote and make decisions. What's on the Agenda? GABA Therapeutics, nestled in leafy Wilmington, is calling its shareholders to a significant gathering. It's not...

Continue Reading
Legal Excellence: Cooper & Trachtenberg Honored

Updated Category News Views 4

Accolades in Family Law: A Consistent Excellence Nothing says "you're doing something right" like repeated recognition from your peers, right? Miriam Cooper and Helena L. Trachtenberg of Cooper Trachtenberg Law Group seem to have nailed it again, being applauded by Best Lawyers® for their relentless dedication to family law. And when something comes up this regularly,...

Continue Reading
Genomma's $1B Debt Plan Spurs Growth Prospects

Updated Category News Views 5

Genomma Secures Major Credit Facility Ever seen a company juggle debt like a pro? That's exactly what Genomma Lab Internacional is up to with their latest move. They've locked in a hefty MXN $1 billion long-term credit facility with Banamex. Now, if that doesn't catch a trader's eye, I don't know what does! Aiming for Financial Reconfiguration The credit they secured...

Continue Reading
S-Transistors Scores €2.6M to Revolutionize Quantum Computing

Updated Category News Views 24

Breaking New Ground in Quantum Computing If you're on the lookout for where the real trailblazers are these days, you've found your ticket with S-Transistors. These Finnish hotshots just scooped up a tidy €2.6 million in pre-seed funding to spearhead something downright revolutionary — superconducting transistors. It's not every day that a startup comes charging out...

Continue Reading
Cricket TV Goes Global with Eluvio's Tech Boost

Updated Category News Views 23

Cricket Australia Teams Up with Eluvio Man, Cricket Australia’s stepping up its game like never before. They've tagged Eluvio to turbocharge Cricket TV, a new direct-to-consumer streaming service. This ain’t just another pipe dream down under; it’s a global play set to seize eyeballs from Melbourne to Mumbai. It’s already out for early birds, with full launch...

Continue Reading
Procept BioRobotics Faces Class Action Over Misleading Claims

Updated Category News Views 0

Here we go, if you sat on Procept BioRobotics (NASDAQ: PRCT) shares looking for that big green ticker, pinch yourself awake. The bumpy ride on the Procept express just veered tragically into class action territory, and you might want to adjust your seats if you've got skin in this game from February 2024 through February 2026. Class actions can be like relentless...

Continue Reading
SiMa.ai and ARK Electronics Propel Drone Innovation

Updated Category News Views 5

Stepping Up Drone Capabilities with Physical AI There's a shift in the drone market landscape that's hard to ignore, and it comes courtesy of a big play by SiMa.ai and ARK Electronics. They’re teaming up to unleash a new wave of autonomous drones, demonstrating how collaboration can shake up the industry. These aren’t just any drones—they're built to be brainy with...

Continue Reading
HUMAIN and MinIO: Transforming AI Infrastructure

Updated Category News Views 6

Game-Changing Partnership in AI Amidst all the commotion at LEAP 2026 in Riyadh, there's a real humdinger of a collaboration between HUMAIN and MinIO that just might redefine AI infrastructure altogether. Forget your piecemeal models—these two want to build an AI-native platform that meshes every piece of the puzzle: data, memory, agents, you name it. It's a gutsy move....

Continue Reading

Top 5 Most Recently Viewed Articles

Heron Therapeutics Gains FDA Approval for ZYNRELEF Access Needle

Updated Category News Views 101

Heron Therapeutics Gains FDA Approval for ZYNRELEF Vial Access Needle Heron Therapeutics, Inc. has some exciting news for those in the healthcare field. The U.S. Food and Drug Administration (FDA) has given the green light to their Prior Approval Supplement Application for the innovative ZYNRELEF Vial Access Needle (VAN). This state-of-the-art device is set to change how...

Continue Reading
Experience Upscale Living at Marlowe Palomar Heights Apartments

Updated Category News Views 126

Marlowe Palomar Heights: Stylish Living, Ready When You Are Greystar, a leader in real estate investment, development, and management, has launched the Marlowe Palomar Heights apartment community—its first Marlowe-branded residential offering in California. Leasing is open now, with new residents scheduled to move in very soon. It’s a fresh start for a community...

Continue Reading
Dan Ives Envisions a Thrilling Tech Landscape by 2026

Updated Category News Views 98

Anticipation for a Transformative Tech Season Renowned tech analyst Dan Ives, associated with Wedbush Securities, maintains his optimistic outlook on the tech industry, identifying this period as one leading into a transformative 2026. He characterizes this upcoming year as a "magical year" for Tesla Inc. (NASDAQ: TSLA) and sees Nvidia Corp. (NASDAQ: NVDA) as a key player...

Continue Reading
Exploring Recent Bullish Sentiment in B. Riley Financial's Options

Updated Category News Views 35

Understanding the Unusual Options Activity in B. Riley Financial Recently, significant activity has been noted in the options market for B. Riley Financial (NASDAQ: RILY). Many investors with substantial capital have adopted a bullish outlook on this financial services company. As this trend unfolds, it’s essential for retail traders and investors to pay close...

Continue Reading
Intermap Technologies Set to Share Q2 Earnings Updates Soon

Updated Category News Views 212

Intermap Technologies Prepares for Second Quarter Earnings Intermap Technologies, recognized as a leader in 3D geospatial products, is set to announce its financial results for the second quarter. The Company has made plans to release these results shortly after market close on a specified Thursday in the future. Live Webinar Details for Stakeholders The Company...

Continue Reading